Advertisements



Two Catalysts For Axovant Sciences In March

Two Catalysts For Axovant Sciences In March.....»»

Category: topSource: seekingalphaFeb 11th, 2019

Upcoming Catalysts Make Axovant Attractive, Jefferies Says In Upgrade

Axovant Sciences Ltd (.....»»

Category: blogSource: benzingaDec 17th, 2018

Why Shares of Plug Power Skyrocketed 34% in March

A range of catalysts helped power this fuel cell leader's stock higher this month......»»

Category: topSource: foxnewsApr 4th, 2019

Liberty Health Sciences: Stock Catalysts In The Lead

Liberty Health Sciences: Stock Catalysts In The Lead.....»»

Category: topSource: seekingalphaApr 4th, 2019

1 High-Yield Dividend Stock to Consider Buying Before March Ends

This pipeline giant has quite a few catalysts coming in April......»»

Category: topSource: foxnewsMar 23rd, 2019

SELLAS Life Sciences Reports 2018 Financial Results and Provides Business Update

NEW YORK, March 22, 2019 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ:SLS) ("SELLAS" or the "Company"), a clinical-stage biopharmaceutical company focused on the.....»»

Category: earningsSource: benzingaMar 22nd, 2019

The Daily Biotech Pulse: Arsanis Completes X4 Merger, EC Nod For Roche, Axovant Offering

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on March 13) read more.....»»

Category: blogSource: benzingaMar 14th, 2019

Mid-Day Market Update: NASDAQ Rises Over 100 Points; Axovant Sciences Shares Surge

Midway through trading Monday, the Dow traded up 0.16 percent to 25,512.72 while the NASDAQ climbed 1.37 percent to 7,522.91. The S&P also rose, gaining 0.85 percent to 2,772.23. Leading and Lagging Sectors read more.....»»

Category: blogSource: benzingaMar 11th, 2019

Stocks That Fell to 3-Year Lows in the Week of March 8

Gilead Sciences, CVS Health, Walgreens and Vodafone reach multiyear lowsRelated Stocks: GILD, CVS, WBA, VOD,.....»»

Category: personnelSource: nytMar 8th, 2019

Major 2019 Biopharma Catalysts Coming in February and March

Here, 24/7 Wall St. has included a calendar of some of the biggest companies expecting clinical trial and U.S. Food and Drug Administration (FDA) updates in February and March......»»

Category: blogSource: 247wallstFeb 8th, 2019

Axovant Sciences reports Q3 EPS (27c), consensus (26c)

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 7th, 2019

March 1st Options Now Available For EXACT Sciences (EXAS)

Stock Options Channel.....»»

Category: topSource: redinewsJan 10th, 2019

Andreas Halvorsen Takes Large Stake in Axovant Sciences

Guru sees value in biotech companyCheck out Andreas Halvorsen Stock Picks » Download GuruFolio Report of Andreas Halvorsen (Updated on 12/20/2018)Related Stocks: AXON, BPMC, BMRN, ANAB, JAZZ, EDIT, EIDX, LIFE, DCPH, ABEO,.....»»

Category: blogSource: gurufocusDec 21st, 2018

Axovant Sciences upgraded to Buy from Hold at Jefferies

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallDec 17th, 2018

Axovant Sciences 30M share Spot Secondary priced at $1.00

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallDec 14th, 2018

Axovant Sciences files to sell common stock, no amount given

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallDec 13th, 2018

Axovant Sciences licenses two gene therapies from UMass Medical School

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallDec 13th, 2018

UPDATE: Axovant shares slide 30% premarket after trial of treatment for sleep disorder fails to meet main goal

Axovant Sciences Ltd. shares slid 30% in premarket trade Monday, after the company said a trial of a treatment for REM sleep behavior disorder in patients with Lewy body dementia failed to meet its main goal. the Basel, Switzerland-base.....»»

Category: topSource: marketwatchDec 10th, 2018

Axovant Sciences nelotanserin Phase 2 study does not meet primary endpoint

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallDec 10th, 2018

Axovant shares slide 24% premarket after trial of treatment for sleep disorder fails to meet main goal

Axovant Sciences Ltd. shares slid 24% in premarket trade Monday, after the company said a trial of a treatment for REM sleep behavior disorder in patients with Lewy body dementia failed to meet its main goal. the Basel, Switzerland-base.....»»

Category: topSource: marketwatchDec 10th, 2018

Axovant Sciences announces feedback from AXO-Lenti-PD pre-IND meeting with FDA

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallDec 6th, 2018